These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14287545)

  • 1. [STUDY OF CHANGES IN BLOOD COAGULATION IN THE COURSE OF MASSIVE SCLEROSING TREATMENTS].
    DOMART A; HODARA M; SAMAMA M; TESLER L
    Phlebologie; 1965; 18():73-7. PubMed ID: 14287545
    [No Abstract]   [Full Text] [Related]  

  • 2. [APROPOS OF THE WORK OF PROF. A. DOMART, DRS. M. HODARA, M. SAMAMA AND L. TESSLER ON CHANGES IN BLOOD COAGULATION IN THE COURSE OF MASSIVE SCLEROSING TREATMENTS].
    TOURNAY R
    Phlebologie; 1965; 18():79-80. PubMed ID: 14287546
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of various sclerosing solutions on blood coagulation parameters in vitro and in patients during sclerosing of varicose veins].
    Brenn H; Imhoff E; Duckert F
    Vasa; 1976; 5(3):199-202. PubMed ID: 969844
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood coagulation studies before and after sclerosing of varicose veins].
    Wuppermann T
    Zentralbl Phlebol; 1971; 10(3):162-9. PubMed ID: 5093626
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the coagulation and fibrinolysis in varicose blood before and after the injection of sclerosing solutions].
    Ludwig H
    Med Welt; 1967 Feb; 7():379-81. PubMed ID: 6045239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coagulation level in sclerosing treatment of esophageal varices].
    Brunner G
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1554. PubMed ID: 3652958
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of the sclerosing agent "hydroxypolyaetoxydodecan" on the coagulation potentials: in vitro investigations.
    Wuppermann T; Haas KH
    Vasa; 1975; 4(1):45-53. PubMed ID: 1189590
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of histology findings and isotope scanning in thrombi due to sclerosing solutions].
    Echtermeyer V; Wuppermann T
    Vasa; 1979; 8(3):217-20. PubMed ID: 516860
    [No Abstract]   [Full Text] [Related]  

  • 9. [State of the coagulation system of the blood following treatment of varicose enlargment of the veins of the lower extremity with phlebosclerosing preparations].
    Liul'ka AN; Pereĭma FA; Berezovskiĭ OI
    Vestn Khir Im I I Grek; 1975 Apr; 114(4):15-8. PubMed ID: 1224506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation parameters after sclerotherapy.
    Baele G; De Vos M; Hublé F; Van Eeghem P; Elewaut A; Barbier F
    Endoscopy; 1986 Jul; 18(4):168. PubMed ID: 3488207
    [No Abstract]   [Full Text] [Related]  

  • 11. [An error too widely spread among the public, even among medical personnel: the risk of hypercoagulation caused by sclerosing solutions].
    Tournay R
    Phlebologie; 1977; 30(2):161-3. PubMed ID: 905335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sodium tetradecyl sulfate as a sclerosing solution in the therapy of esophageal varices].
    Ohashi M; Iwase H; Horiguchi H; Nakane M; Nagata J
    Nihon Rinsho; 1990 Apr; 48(4):722-6. PubMed ID: 2366359
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in thrombin-antithrombin III complex after endoscopic injection sclerotherapy.
    Takada K; Matsumoto A; Miyoshi H; Oshiba S
    Am J Gastroenterol; 1991 Jan; 86(1):123-4. PubMed ID: 1986546
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of varicose veins of the lower extremities with phlebosclerosing preparations].
    Liul'ka AN; Pereĭma FA
    Khirurgiia (Mosk); 1980 Apr; (4):88-91. PubMed ID: 7374089
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of coagulation in cirrhotics after endoscopic variceal schlerotherapy.
    de Franchis R; Cipolla M; Primignani M; Agape D; Antoniozzi F; Torgano G; Vecchi M; Vitagliano P; Vigano S; D'Angelo A
    Am J Gastroenterol; 1987 Dec; 82(12):1287-91. PubMed ID: 3500636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of venous diseases].
    Santler R
    Wien Med Wochenschr; 1974 Oct; 124(42-43):607-10. PubMed ID: 4439954
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo effects of foam sclerotherapy on coagulation.
    Shadid NH; van der Velden SK; van Oerle R; Ten Cate H; Sommer A; Nelemans P
    Phlebology; 2014 Jun; 29(5):287-92. PubMed ID: 23535444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental research on histological changes of the liver caused by injection on sclerosing solutions in the hepatic circulation].
    DOCIMO R; PELLEGRINI L
    G Ital Chir; 1956 Apr; 12(4):196-212. PubMed ID: 13344997
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro effects of detergent sclerosants on clot formation and fibrinolysis.
    Parsi K; Exner T; Low J; Fung Ma DD; Joseph JE
    Eur J Vasc Endovasc Surg; 2011 Feb; 41(2):267-77. PubMed ID: 21183368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TISSUE RESPONSE TO SCLEROSING SOLUTIONS.
    DUBIT JA; KRUGER GO
    J Oral Ther Pharmacol; 1964 Sep; 1():156-60. PubMed ID: 14205655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.